DOI:
10.1055/s-00037682
International Journal of Epilepsy
LinksClose Window
References
Blumenthal GM, Cortazar P, Zhang JJ. et al.
FDA approval summary: sunitinib for the treatment of progressive well-differentiated locally advanced or metastatic pancreatic neuroendocrine tumors.
Oncologist
17 (08) 2012; 1108-1113
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.